About Big Health Leading Stocks List
Health concept stocks include 109 listed companies such as China TaiBao, Pharmacopeia, Aier Ophthalmology, Zhifei Biologicals, BOE A, Guotai Junan, Yunnan Baiyao, Fosun Pharmaceuticals, Tiger Pharmaceuticals and Kanglong Huacheng. Which are the leading health stocks? The following Xiao Biao brought about the health leading stocks, we take a look at it, I hope to bring reference.
Health Leading Stocks List
Leading Stocks 1, Lexin Medical: The company's business has the research and development and operation of intelligent health cloud platform.
Leading stocks 2, Rongjie health: the company is engaged in far-infrared health equipment research and development, production and sales.
Leading stock 3, Yuexin health: the company is mainly engaged in the health industry, architectural ceramics business, ecological health building materials business.
Health leading stocks of the recent situation
Leisure Heart Medical: leading stocks
In the last 5 days of Lexin Medical shares fell 4.04%, the total market value fell 83.7335 million, the current market value of 2.074 billion yuan. 2022 stock price fell -72.05%. December 21 news, Lexin Medical December 21 main fund net outflow of 1.4636 million yuan, large single net outflow of 1.4636 million yuan, retail fund net outflow of 1.3485 million yuan.
Rongjie Health: leading stocks
In the last five trading days, the stock price fell 7.77%, the highest price of $4.11, the total market value fell by 233 million.December 21 news, Rongjie Health main net inflow of 4,510,300 yuan, large single net inflow of 1,119,000 yuan, retail net outflow of 1,831,800 yuan.
Rongjie Health: leading stocks
In the last five trading days, the stock price rose 7.74%, the highest price of 5.39 yuan, the total market value rose 361 million, the current market value of 4.67 billion yuan. Funds flow data, on December 21, the main funds net outflow of 950,915,000 yuan, super-large single net outflow of 780,502,000 yuan, large single net outflow of 17,041,300 yuan, retail funds net inflow of 71,777,000 yuan.
Lexin Medical (300562)
The financial report shows that in the third quarter of 2022, the company's operating income of 299 million yuan; net profit attributable to listed shareholders of 2,054,900 yuan; fully diluted return on net assets of 0.19%; gross profit margin of 23.24%, earnings per share of 0.01 yuan.
Rongjie Health (300247)
Rongjie Health released its Q3 2022 financial results, realizing operating income of 94.5235 million yuan, an increase of -4.88% year-on-year, and net income of 3.7131 million yuan, -82.7% year-on-year.
Yuexin Health (002162)
The financial report shows that in the third quarter of 2022, the company achieved operating income of 350 million yuan; net profit attributable to listed shareholders of -76,945,000 yuan; fully diluted return on net assets of -6.22%; gross profit margin of 20.6%, and earnings per share of -0.08 yuan.
Health-related stocks what else
1, Annaier (002875): the company is mainly engaged in high-end children's clothing business. December 21, Annaier opening quote 23.2 yuan, closed at 25.380 yuan, up 10.01%. The day's highest price of 25.38 yuan, the lowest reached 22.51 yuan, the volume of 28.224 million lots, the total market value of 5.397 billion yuan.
2, Guolian aquatic (300094): the company's main business for shrimp and tilapia seedlings, aquatic feed, primary processing products and deep-processed food. Southern wealth network on December 21, Guolian aquatic shares rose 6.07%, as of the closing price of 6.470 yuan, market value of 7.334 billion yuan. Intraday stock price peak price of 6.68 yuan, as low as 6.1 yuan, turnover 145 million lots.
3, Hai Zheng Pharmaceutical (600267): the company is mainly engaged in the research and development of APIs, preparations, production and sales. Southern wealth network on December 21, Hai Zheng Pharmaceutical shares rose 4%, as of the closing price of 11.190 yuan, market value of 13.408 billion yuan. The highest price of the stock price of 11.69 yuan, the lowest reached 10.82 yuan, the volume of 28,231,500 lots.
4, Shu Hua sports (605299): the company is mainly engaged in fitness equipment and display rack products research and development, production and sales. December 21 evening resumption of news, Shu Hua sports latest reported 11.170 yuan, up 2.95%. Volume of 9,151,900 lots, total market capitalization of 4.596 billion yuan.
5, nine Ann medical (002432): the company's business has the research and development, production and sales of home medical equipment. Beijing time on December 21, nine Ann medical opening quote 59.24 yuan, closed at 60.820 yuan, compared with the previous trading day's close up 2.65% at 59.25 yuan. The day's highest price of 61.56 yuan, the lowest reached 58.88 yuan, with a turnover of 28.177 million lots, a total market capitalization of 29.45 billion yuan.
6, Xi Wang Foods (000639): the company's main business for the Xi Wang brand series of healthy edible oil. December 21, Xi Wang Foods evening resumption of the news, the stock price fell 0.41% in 7 days, this year's gains fell -6.12%, the latest at 4.900 yuan, up 2.3%, the market value of 5.289 billion yuan.
7, light media (300251): the company is engaged in the film business. December 21 evening resumption of news, light media 5 days within the share price fell 4.36%, this year's gain fell -56.61%, the latest reported 8.250 yuan, turnover 120 million yuan.
8, Kexing Pharmaceuticals (688136): the company is engaged in the research and development, production and sales of biological drugs business. December 21 news, Kexing Pharmaceuticals opened at 24.21 yuan, closed at 24.800 yuan, up 2.44%. The day's highest price of 25.36 yuan, the lowest reached 24.1 yuan, the total market value of 4.928 billion.
Honeysuckle stock code
1, Zhendong Pharmaceuticals is a listed company of Zhendong Health Industry Group (stock code: 300158), has formed a planting, research and development, production and sales as one of the health industry chain, mainly producing anti-tumor, cardio-cerebral and vascular, anti-infective and so on. The largest domestic production of honeysuckle listed companies is Zhendong Pharmaceuticals.
2, Lianhua Qingdian is which listed companies produce Lianhua Qingdian listed companies are only the following two: Ealing Pharmaceuticals, stock code 002603; Zhendong Pharmaceuticals, stock code 300158. Lianhua Qingdian capsule: leading Ealing Pharmaceuticals. Zhendong Pharmaceuticals has forsythia, honeysuckle, platycodon, licorice, etc., which are needed for Lianhua Qingdian capsule.
3. Hello, glad to answer your question, which stock does compound honeysuckle granules belong to? Daqing Huake stock. Hope it can help you, thank you.
4, listed. According to the query Zhenao Honeysuckle Pharmaceutical Co. related information shows that Zhenao Honeysuckle Pharmaceutical Co. is listed, the company was listed in 2017, will be issued by the State Council or the State Council authorized by the securities management department approved to be listed and traded on the stock exchange.
Menian Health stock code
Antigen detection stocks include Menian Health, Heavy Pharmaceuticals Holding, Heron Pharmaceuticals, Haili Biologicals, Botuo Biologicals, Meikang Biologicals, Mike's Biologicals, Wanfu Biologicals, Thousands of Red Pharmaceuticals and Dongfang Biologicals.
Jiangsu Sanyou Group Co., Ltd. was listed on the Shenzhen Stock Exchange on May 18, 2005, the main underwriter is Guoyuan Securities Co., Ltd. and the listing sponsor is Guoyuan Securities Co., Ltd. and the stock code is 002044.
It is listed under the stock code of 300015. yunnanbaiyao yunnanbaiyao is the first batch of national innovative enterprises, and its main business are pharmaceuticals, health products, traditional Chinese medicine resources and pharmaceutical logistics.
When it comes to the mass health checkup market, MENI Health has two major brands, MENI Health and Ciming, as its core market coverage; high-end group health checkups, comprehensive medical service market and high-end personal health checkups. The company also provides high-level quality services through the brands "Aoya" and "MJ".
According to the plan of MNH, after the acquisition of Ciming, MNH and Ciming will be called two subsidiaries of the listed company, with their own boards of directors, and will remain independent of each other in terms of their respective management teams, sales, finances, and manpower.
What are the leading stocks in big health stocks
Yuexin Health (002162), Shanghai Yuexin Health Group Co. is engaged in the business of large-scale health industry, architectural ceramics business and ecological and healthy building materials business. The company's 2020 total operating income of $19.5 billion, an increase of 44%; gross profit of 3. Net profit of $38.1 billion, net profit of 35.17 million yuan.
Lejin health (300247): a high proportion of equity incentives highlights the long-term development of confidence in incentive objects covering a wide range of objects, performance conditions require high, to achieve the long-term interests of binding.
(3) the research and development, production and sales of health products; and (4) medical services, health management, health care pension and other health industry investment. China Resources Sanjiu: leading pharmaceutical stocks. 2015 annual pharmaceutical industry profit is expected to be 2,602 billion yuan, an increase of 11,9% year-on-year, the growth rate fell 0,4 percentage points year-on-year.
The top 10 leading Chinese medicine stocks are Pientzehuang, Yunnan Baiyao, Jiuzhitang, Essence Pharmaceuticals, Tongrentang, Baiyunshan, Kangyuan Pharmaceuticals, Jiangzhong Pharmaceuticals, Guangzhuyuan, Ma Yinglong.China's healthcare service industry market size reached 6 trillion yuan in 2019, 2015-2019 CAGR 12%, and it is estimated that it will reach 10 trillion yuan in 2030.
Future cross-border intermingling with the smart home, the Internet of cars, industrial Internet, etc. will be the development trend, artificial intelligence, industrial Internet of things, biotechnology, big health and other directions will become the market hotspot in 2017, the smartphone market will also maintain a relatively strong demand, which will give the cell phone distribution industry to bring sustained development opportunities.
New Era Health Industry Group listing time
1, the listing time of the new era of health industry, may have to wait until the company's preparations are completed, complete the listing procedures, after the relevant departments to review and approve the substantial progress.
2, is the direct selling industry in the earliest direct selling license one of the domestic enterprises, but also direct selling industry in the only central enterprise. 2006 August 16, the new era of health industry (Group) Co., Ltd. has obtained the Chinese people *** and the Ministry of Commerce issued the "direct selling license," is the national high-tech enterprises. It is a national high-tech enterprise.
3. On August 16, 2006, New Era Health Industry (Group) Co., Ltd. obtained the "Direct Selling License" issued by the Ministry of Commerce of the People's Republic of China, which is a national high-tech enterprise.
4, there is no specific news about the listing of the original shares of New Era, according to the news released on December 25, 2019, the New Era Health Industry (Group) Company is going to be listed in Hong Kong H-shares, but there is no clear news that it has already been listed, and the company has had news of the original shares from around 2016, but still not listed.
5, July 3, 2003, Sany Heavy Industry successfully listed on the Shanghai Stock Exchange, stock code 600031. July 30, 2003, Sany Heavy Machinery Co., Ltd. was established, under the jurisdiction of excavator division, piling machinery division, new materials division.
What are the shares of Chinese medicine
Taiantang: In the past 7 trading days, Taiantang fell 26%, with the highest price of 48 yuan, and the total market value fell 5.1 billion yuan, or 26%. Yisheng Pharmaceuticals: Looking back at the past 7 trading days, Yisheng Pharmaceuticals fell for 6 days in a row.
Chinese medicine stocks include WuXi AppTec, Fangsheng Pharmaceutical, Hengrui Pharmaceutical, Duo Rui Pharmaceutical, Erkang Pharmaceutical, Essence Pharmaceutical, Buchang Pharmaceutical, Fosun Pharmaceutical, Beida Pharmaceutical, and Foji Pharmaceutical.
What are the leading stocks of traditional Chinese medicine: 1 Pientzehuang; 2 Yunnan Baiyao; 3 Jiuzhitang; 4 Tongrentang; 5 Baiyunshan; 6 Jiangzhong Pharmaceutical; 7 Ma Yinglong. In addition, the Chinese medicine stocks are: Haiwang Bio, Fengyuan Pharmaceuticals, Dong'a Ajiao, Lizhu Group and so on.
Guangzhou Pharmaceuticals: Guangzhou Pharmaceuticals Co., Ltd. by the Guangzhou Pharmaceutical Group Co., Ltd. under the eight proprietary Chinese medicine manufacturing enterprises and three medical Guangzhou Pharmaceuticals Co., Ltd. drug trading enterprises in September 1, 1997 reorganization was established. Dong'a Colla Corii Asini: Dong'a Colla Corii Asini has been a royal tribute from the Han and Tang dynasties to the Ming and Qing dynasties.
The leading stocks of listed companies of proprietary Chinese medicine are: Pientzehuang (600436): the leading stock of proprietary Chinese medicine. Pientzehuang, a traditional precious Chinese patent medicine exclusively produced by the company, has a history of more than 450 years, which originated from the court and has been handed down among the people, and has formed an excellent reputation due to its unique and miraculous curative effect, and is regarded as "National Treasure and Famous Medicine" by the domestic and foreign traditional Chinese medicine circles.
Cheung Kong Health stock potential
Cheung Kong Health stock potential, recently Cheung Kong Health stock has been on the rise, is a very potential stock.
Can. Yangtze River Health stock trend is good, the development of space, stock potential, long-term investment value is greater, very suitable for long-term holding.
Cheung Kong Health can not be shipped. Yangtze River health main funds in the early stage is not much willingness to enter the field, have been in the state of red and green flat, so it has always been in the stage of shock, the late appearance of red, fat and green, the main force willingness to enter the field is strong, began to continue to break out, the late market is more considerable.
Before I started to analyze Guangyuyuan, I prepared a list of leading stocks in the pharmaceutical manufacturing industry. You can take a look at: treasure information: pharmaceutical manufacturing industry leading stocks at a glance 1. from the company's point of view, the company introduction: Guangyuyuan was founded in 1541 AD, so far has a history of 500 years of development.
Reviewing the last 30 trading days, CK Health stock price rose 51%, the total market capitalization rose 7.8 billion, the current market capitalization of 69.7 billion yuan. 2022 stock price rose 41%. Baby Friendly Room in terms of net profit, from 2017 to 2020, respectively, 93.58 million yuan, 200 million yuan, 5.4 billion yuan, 1.7 billion yuan.